MPM Oncology Impact Management is a fund manager in Chestnut Hill with $1.19 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
364818254
SEC advisor number
801-106988
FINRA CRD number
281892
AUM ?
$1.19 bn
(as of 29 Mar 21)
Accounts
3
(as of 29 Mar 21)
Employees
7
(5 investment advisory or research)
Address
MPM Oncology Impact Management
450 KENDALL STREET
CAMBRIDGE
MA 02142
450 KENDALL STREET
CAMBRIDGE
MA 02142
Office hours
Monday - Friday, 9 AM TO 5 PM
Phone
6174259200
Ownership
Owner | Title | From | %Ownership |
---|---|---|---|
Gadicke, Ansbert, S | Partner | 12/2018 | 25-50% |
MPM Founders LLC | Partner | 12/2018 | 10-25% |
Evnin, Luke, Basil | Member | 11/2015 | 50-75% |
Gadicke 2012 Irrevocable Trust | Member | 11/2015 | 25-50% |
Bardon, Christiana, Goh | Trustee | 11/2015 | |
Gadicke, Ansbert, S | Trustee | 01/2012 | |
Karger, Paul | Trustee | 01/2015 | |
Gadicke, Ansbert, S | Trustee | 01/2015 | |
Karger, Paul | Trustee | 01/2015 | |
Laguerre, Kristen, Lee | Chief Financial Officer and Chief Operations Officer | 10/2019 | < 5% |
Mcgrath, Nicholas, Myles | General Counsel and Chief Compliance Officer | 06/2019 | < 5% |
Acg Investment Holdings, LLC | Partner | 12/2018 | 5-10% |
Acg Investment Holdings Series #1 | Partner | 12/2018 | 10-25% |
Ansbert K. Gadicke 2015 Irrevocable Trust II | Member | 05/2019 | > 75% |
Christiana G. Bardon 2015 Irrevocable Trust II | Member | 05/2019 | > 75% |
Ansbert K. Gadicke 2015 Irrevocable Trust II | Member | 11/2015 | 25-50% |
Ownership
Fund structure | AUM | Fund type |
---|---|---|
MPM Oncology Impact Management, L.P. | $1.19 bn | |
Ubs Oncology Impact Fund L.P. | $1.19 bn | Other Private Fund |
Ubs Oncology Impact Fund (Cayman) Investor LTD. | ||
Ubs Oncology Impact Fund (Cayman) Investor L.P. |
Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
13 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
SC 13D/A
Reunion Neuroscience Inc.
1 Aug 23
SC 13D
Reunion Neuroscience Inc.
12 Jun 23
4
TCR2 THERAPEUTICS INC.
5 Jun 23
13F-HR
Quarterly holdings report by institutional manager
12 May 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 22
13F-HR
Quarterly holdings report by institutional manager
11 Aug 22